GoodRx Holdings Inc (GDRX)
7.10
+0.09
(+1.28%)
USD |
NASDAQ |
May 03, 16:00
7.115
+0.02
(+0.21%)
After-Hours: 20:00
GoodRx Holdings Cash from Financing (TTM): -167.40M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -167.40M |
| September 30, 2023 | -46.58M |
| June 30, 2023 | -54.58M |
| March 31, 2023 | -42.92M |
| December 31, 2022 | -120.23M |
| September 30, 2022 | -126.90M |
| June 30, 2022 | -109.37M |
| Date | Value |
|---|---|
| March 31, 2022 | -107.91M |
| December 31, 2021 | -30.53M |
| September 30, 2021 | -130.44M |
| June 30, 2021 | 865.86M |
| March 31, 2021 | 864.20M |
| December 31, 2020 | 905.82M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-167.40M
Minimum
Dec 2023
905.82M
Maximum
Dec 2020
130.69M
Average
-54.58M
Median
Jun 2023
Cash from Financing (TTM) Benchmarks
| Sharecare Inc | -11.73M |
| American Well Corp | 2.147M |
| MultiPlan Corp | -180.99M |
| Privia Health Group Inc | 3.705M |
| GeneDx Holdings Corp | 53.14M |